Dhathri Ayurveda Receives License for Manufacturing AYUSH 64- Covid Management Tablet

KOCHI:
Dhathri has attained licence for the manufacture of Ayush 64, Covid preventive tablet, developed by Central Council for Research in Ayurvedic Science (CCRAS) functioning under Aysuh, the Central Ayurveda Research Ministry.

Dhathri Ayurveda is the first Ayurveda medicine manufacturer which received the licence in Kerala for the production of Aysuh 64. This tablet can prevent Covid the disease in patients who show mild symptoms.

The first batch of the medicine was received by Supreme Court former judge Justice K T Thomas from Dhathri Ayurveda Research and Development executive vice president Dr Rajesh Kumar. Dhathri Ayurveda Managing Director Dr Sajikumar, Dhathri Ayurveda Business Strategy executive vice president Bipin Cherian were also present.

Ayush 64 has been included in the national clinical management protocol for the treatment of asymptomatic, mild and moderate Covid disease. Ayush 64 has undergone scientific validation through hospital clinical trials under the joint intiatiVe of CSIR and Ministry of Ayush.